APOP Stock Soars 50% on a Major Deal with Canndoc
In a development that has taken the market by surprise today, lightly traded APOP stock soared in today’s trading session after important news emerged about Cellect Biotechnology Ltd (NASDAQ:APOP). Investors Cheer the News Cellect has ... [Read]
APOP Stock Doubles on Solid Outcome of ApoGraft
APOP stock is having a solid day with a gain of over 100% after Cellect Biotechnology Ltd. (NASDAQ:APOP) reported positive results from its ongoing Phase 1/2 clinical study of ApoGraft. Solid News One stock that ... [Read]
Biotechnology Stocks On The Rise, Ampliphi Biosciences Corp Makes A 16% Rally After Clinical Treatment Success
Biotechnology stocks are doing extremely well on the exchanges today, as a few biotech companies around the world announced clinical trial successes this morning. AmpliPhi Biosciences Corp. (AMX:APHB) has shown a large rally, as the ... [Read]
Successful Stem Cell Breakthrough Launches Cellect Biotechnology Ltd Stock Up Nearly 50%
Cellect Biotechnology Ltd. (NASDAQ:APOP) is having a great start on the trading floor this morning after announcing the breakthrough results of its clinical stem cell trial. The Israeli based company has stated that it has ... [Read]